A novel modified RANKL variant can prevent osteoporosis by acting as a vaccine and an inhibitor
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
A novel modified RANKL variant can prevent osteoporosis by acting as a vaccine and an inhibitor
Authors
Keywords
-
Journal
Clinical and Translational Medicine
Volume 11, Issue 3, Pages -
Publisher
Wiley
Online
2021-03-17
DOI
10.1002/ctm2.368
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- A new vaccine targeting RANKL, prepared by incorporation of an unnatural Amino acid into RANKL, prevents OVX-induced bone loss in mice
- (2018) Feng Li et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Effects of RANKL Knockdown by Virus-like Particle-Mediated RNAi in a Rat Model of Osteoporosis
- (2018) Daniel B. Hoffmann et al. Molecular Therapy-Nucleic Acids
- A novel recombinant RANKL vaccine prepared by incorporation of an unnatural amino acid into RANKL and its preventive effect in a murine model of collagen-induced arthritis
- (2018) Tailin Wu et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Severe hypocalcaemia and hypophosphataemia following intravenous iron and denosumab: a novel drug interaction
- (2016) B. Smyth et al. INTERNAL MEDICINE JOURNAL
- LGR4 is a receptor for RANKL and negatively regulates osteoclast differentiation and bone resorption
- (2016) Jian Luo et al. NATURE MEDICINE
- Peptide-based synthetic vaccines
- (2016) Mariusz Skwarczynski et al. Chemical Science
- Hypocalcemia Post Denosumab in Patients with Chronic Kidney Disease Stage 4-5
- (2015) Vatsa Dave et al. AMERICAN JOURNAL OF NEPHROLOGY
- Denosumab for the treatment of osteoporosis
- (2015) Sarah Zaheer et al. Expert Opinion on Drug Metabolism & Toxicology
- In a Class of Their Own – RXFP1 and RXFP2 are Unique Members of the LGR Family
- (2015) Emma J. Petrie et al. Frontiers in Endocrinology
- Osteoporosis Prevention, Screening, and Treatment: A Review
- (2014) Juliana M. Kling et al. JOURNAL OF WOMENS HEALTH
- Effects of RANKL-Targeted Therapy in Immunity and Cancer
- (2014) Michael L. Cheng et al. Frontiers in Oncology
- Osteoclasts: New Insights
- (2013) Feng Xu et al. Bone Research
- Therapeutic role of a vaccine targeting RANKL and TNF-α on collagen-induced arthritis
- (2012) Huihui Yuan et al. BIOMATERIALS
- Role of RANK Ligand and Denosumab, a Targeted RANK Ligand Inhibitor, in Bone Health and Osteoporosis: A Review of Preclinical and Clinical Data
- (2012) David W. Dempster et al. CLINICAL THERAPEUTICS
- Bench to bedside: elucidation of the OPG–RANK–RANKL pathway and the development of denosumab
- (2012) David L. Lacey et al. NATURE REVIEWS DRUG DISCOVERY
- RANKL Employs Distinct Binding Modes to Engage RANK and the Osteoprotegerin Decoy Receptor
- (2012) Christopher A. Nelson et al. STRUCTURE
- Active vaccination with Dickkopf-1 induces protective and therapeutic antitumor immunity in murine multiple myeloma
- (2011) J. Qian et al. BLOOD
- Lgr5 homologues associate with Wnt receptors and mediate R-spondin signalling
- (2011) Wim de Lau et al. NATURE
- Immunological mechanisms of vaccination
- (2011) Bali Pulendran et al. NATURE IMMUNOLOGY
- Evidence for osteocyte regulation of bone homeostasis through RANKL expression
- (2011) Tomoki Nakashima et al. NATURE MEDICINE
- Selective targeting of RANK signaling pathways as new therapeutic strategies for osteoporosis
- (2010) Joel Jules et al. EXPERT OPINION ON THERAPEUTIC TARGETS
- Receptor Activator of NF-κB (RANK) Ligand Induces Ectodomain Shedding of RANK in Murine RAW264.7 Macrophages
- (2010) Akihiro Hakozaki et al. JOURNAL OF IMMUNOLOGY
- Structural and Functional Insights of RANKL-RANK Interaction and Signaling
- (2010) C. Liu et al. JOURNAL OF IMMUNOLOGY
- Therapeutic antibodies, vaccines and antibodyomes
- (2010) Dimiter S. Dimitrov mAbs
- Regulation of bone formation and remodeling by G-protein-coupled receptor 48
- (2009) J. Luo et al. DEVELOPMENT
- Mutations within the TNF-Like Core Domain of RANKL Impair Osteoclast Differentiation and Activation
- (2008) Taksum Cheng et al. MOLECULAR ENDOCRINOLOGY
- Deletion of G protein-coupled receptor 48 leads to ocular anterior segment dysgenesis (ASD) through down-regulation of Pitx2
- (2008) J. Weng et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started